Kite Pharma, Inc. (NASDAQ: KITE) Starts Presentation at 29th Annual ROTH Conference
Kite Pharma (NASDAQ: KITE) is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies. The company aims to achieve its goal of providing rapid, long-term durable response and eliminating the burden of chronic care through the development of cancer immunotherapies. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information, visit the company’s website at www.kitepharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…







